This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,938.54, is a Firm Fixed Price Delivery Order for the supply of ZOLADEX 3.6 MG IMPLANT SYRNS, a pharmaceutical product. The contract has an ultimate completion date of January 17, 2025.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award reviewed is a specific delivery order placed under this larger IDC with the DLA.
The contract was not set aside for any specific business designation. Amerisourcebergen is a for-profit organization registered in the System for Award Management (SAM.gov) and has been a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems.
Generated 3/27/25, 9:45 AM